Trial Profile
Compliance of patients with essential hypertension treated with candesartan [candesartan cilexetil] or candesartan/hydrochlorothiazide (CoCa)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Candesartan cilexetil/hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Acronyms CoCa
- Sponsors AstraZeneca
- 05 Mar 2008 New trial record.